Myomo, Inc.

MYO - Financial Snapshot

Metrics for MYO

Price $1.09
Shares Outstanding 38.64M
All-Time Low $0.37
52-Week Low $0.71

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((15,696,404 - 27,752,006) / 38,638,653) = -0.312
Net Current Assets / Share $-0.05
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((25,657,818 - 27,752,006) / 38,638,653) = -0.0542
Net Tangible Assets / Share $0.19
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((36,753,687 - 1,757,402 - 27,752,006) / 38,638,653) = 0.19
Avg CA Burn (Quarterly %) 6.59% (as of 5-30-2026)

Earning Metrics

Max Earning Power / Share $-0.66
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((-2,685,395 / 0.105) / 38,638,653) = -0.6619
Adjusted Earning Power $-0.74
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-3,009,399 / 0.105) / 38,638,653) = -0.7418
Non-Cash Charges to Market Cap 1.12%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Q) 0 (as of 5-30-2026)
Avg Net Income (5Q) -3.5M (as of 5-30-2026)
Data as of: Price 05-29-26 16:00 ET, Balance Sheet 2026-03-31, Income Statement 2026-03-31, Cash Flow 2026-03-31

Indicators

Dividend indicators Value Date
Current Dividend Streak No 5-30-2026
Consecutive Years Paid No 5-30-2026
Pays Dividend No 5-30-2026
Last Dividend Date 1-30-20
Income indicators Value Date
Current Dividend Streak No 5-30-2026
EBITDA Positive No 5-30-2026
Net Income Positive No 5-30-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 3 quarterly.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2026-03-31 Quarterly $0.19 7.2M ($7,244,279) 38.6M (38,566,250)
2025-12-31 Quarterly $0.26 9.8M ($9,812,603) 38.5M (38,471,356)
2025-09-30 Quarterly $0.38 14.6M ($14,625,583) 38.4M (38,433,260)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-05-11 38,638,653 -30
2026-05-01 38,638,683 +126,968
2026-03-17 38,511,715 +76,191

Short Interest Changes

Latest short-interest change: 3,811,428 shares (11.23% of float) | Days to cover: 10.79

Date Short Interest Delta Δ %
2026-05-28 3,811,428 shares -29,044 -0.76%
2026-05-14 3,840,472 shares -50,089 -1.29%
2026-04-27 3,890,561 shares +103,954 +2.75%
2026-04-13 3,786,607 shares -1,102,408 -22.55%
2026-03-24 4,889,015 shares +300,522 +6.55%
2026-03-11 4,588,493 shares -177,991 -3.73%
2026-02-26 4,766,484 shares +46,447 +0.98%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.